EUVIMEDEUVIMED entdecken
Crossref

Polymorphonuclear phenotypical expression of CD18, at baseline and after in vitro activation, in several clinical disorders: Revision of our case series

Gregorio Caimi, Rosalia Lo Presti, Caterina Carollo, Maria Montana, Melania Carlisi

Clinical Hemorheology and Microcirculation · 2023

DOI: 10.3233/ch-231771 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Hemorheology and Microcirculation, 2023. Verfasst von Gregorio Caimi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, Palermo, Italy. Hauptthemen laut MEDLINE: CD18 Antigens, Neutrophils. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 120 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: In relation to the different and important roles of the beta2 integrins, we have revisited the expression of polymorphonuclear leukocyte CD18 in several clinical disorders, at baseline and after in vitro activation. SUBJECTS: we have examined subjects with type 1 diabetes mellitus, vascular atherosclerotic disease, type 2 diabetes mellitus without and with macrovascular complications, chronic renal failure on conservative treatment, essential hypertension, deep venous thrombosis, acute ischemic stroke and subjects with venous leg ulcers. METHODS: unfractioned leukocyte suspension was prepared according to the Mikita’s method, while the leukocyte were separated into mononuclear and polymorphonuclear cells with a Ficoll-Hypaque medium. Using specific monoclonal antibody, the CD18 expression was evaluated with cytofluorimetric analysis, using FACScan (Becton Dickinson) be Cellquest software; the activation in vitro with PMA was effected according to modified Yasui and Masuda methods. RESULTS: in type 1 diabetes mellitus, at baseline CD18 is under expressed in comparison with normal control, and not changes after PMA activation were observed; in subjects with vascular atherosclerotic disease, in type 2 diabetes mellitus CD18 is over expressed at baseline but does not vary after activation; in subjects with chronic renal failure, essential hypertension and in subjects with acute ischemic stroke the CD18 up-regulate at baseline compared to normal control, and it increases further after activation; in subjects with deep venous thrombosis the CD18 expression is not different from control group at baseline, but it increases after activation; finally, in subjects with venous leg ulcers the CD18 is normally expressed at baseline, and it does not change after PMA activation. CONCLUSIONS: in the different clinical disorders, the trend of this integrin subunit provides some specific information, useful to select the best therapeutic strategy in clinical practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CD18 AntigensNeutrophilsHumansMaleFemaleMiddle AgedDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1AdultAgedAtherosclerosisKidney Failure, ChronicHypertensionVenous Thrombosis

Stichwörter der Autor:innen

Polymorphonuclear CD18 expressionacute ischemic strokechronic renal failuredeep venous thrombosisessential hypertensiontype 1 diabetes mellitustype 2 diabetes mellitusvascular atherosclerotic diseasevenous leg ulcers

Substanzen

CD18 Antigens

Autor:innen und Institutionen

  • Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, Palermo, Italy.
  • Department of Psychology, Educational Science and Human Movement, University of Palermo, Palermo, Italy.

Zitieren

APA

Caimi, G., Lo Presti, R., Carollo, C., Montana, M., & Carlisi, M. (2023). Polymorphonuclear phenotypical expression of CD18, at baseline and after in vitro activation, in several clinical disorders: Revision of our case series. Clinical Hemorheology and Microcirculation. https://doi.org/10.3233/ch-231771

Vancouver

Caimi G, Lo Presti R, Carollo C, Montana M, Carlisi M. Polymorphonuclear phenotypical expression of CD18, at baseline and after in vitro activation, in several clinical disorders: Revision of our case series. Clinical Hemorheology and Microcirculation. 2023. doi:10.3233/ch-231771

BibTeX
@article{Caimi2023,
  author = {Caimi, Gregorio and Lo Presti, Rosalia and Carollo, Caterina and Montana, Maria and Carlisi, Melania},
  title = {Polymorphonuclear phenotypical expression of CD18, at baseline and after in vitro activation, in several clinical disorders: Revision of our case series},
  journal = {Clinical Hemorheology and Microcirculation},
  year = {2023},
  doi = {10.3233/ch-231771}
}
Kostenlos starten →